Comparing the EQ-5D-5L utility index based on value sets of different countries: impact on the interpretation of clinical study results
Abstract Objective To compare the country-specific value sets of the EQ-5D-5L utility index and to evaluate the impact on the interpretation of clinical study results. Six country value sets from Canada, England, Japan, Korea, Netherlands and Uruguay were obtained from literature. In addition, ten c...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-01-01
|
Series: | BMC Research Notes |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13104-019-4067-9 |
id |
doaj-54e63e0c3bc745459af9d27abe8df146 |
---|---|
record_format |
Article |
spelling |
doaj-54e63e0c3bc745459af9d27abe8df1462020-11-25T02:05:43ZengBMCBMC Research Notes1756-05002019-01-011211610.1186/s13104-019-4067-9Comparing the EQ-5D-5L utility index based on value sets of different countries: impact on the interpretation of clinical study resultsChristoph Gerlinger0Luke Bamber1Friedhelm Leverkus2Carsten Schwenke3Claudia Haberland4Gilda Schmidt5Jan Endrikat6Statistics and Data Insights, Bayer AGHealth Economics and Outcomes Research, Bayer AGHealth Economics and Outcomes Research, Pfizer Deutschland GmbHSCOSSISHealth Economics and Outcomes Research, Bayer AGObstetrics and Gynecology, Saarland UniversityObstetrics and Gynecology, Saarland UniversityAbstract Objective To compare the country-specific value sets of the EQ-5D-5L utility index and to evaluate the impact on the interpretation of clinical study results. Six country value sets from Canada, England, Japan, Korea, Netherlands and Uruguay were obtained from literature. In addition, ten crosswalk value sets were downloaded from the EuroQol.org website. Results For each of the 3125 possible health states the difference between the country with the highest index and the country with the lowest index was calculated. The median difference was 0.417 across the health states. When analyzing multinational clinical studies, country-specific value sets should be used to evaluate treatment effects. Additional country-specific analyses are needed.http://link.springer.com/article/10.1186/s13104-019-4067-9EQ-5D-5L utility indexClinical studiesCountry differencesQuality of life valuation |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Christoph Gerlinger Luke Bamber Friedhelm Leverkus Carsten Schwenke Claudia Haberland Gilda Schmidt Jan Endrikat |
spellingShingle |
Christoph Gerlinger Luke Bamber Friedhelm Leverkus Carsten Schwenke Claudia Haberland Gilda Schmidt Jan Endrikat Comparing the EQ-5D-5L utility index based on value sets of different countries: impact on the interpretation of clinical study results BMC Research Notes EQ-5D-5L utility index Clinical studies Country differences Quality of life valuation |
author_facet |
Christoph Gerlinger Luke Bamber Friedhelm Leverkus Carsten Schwenke Claudia Haberland Gilda Schmidt Jan Endrikat |
author_sort |
Christoph Gerlinger |
title |
Comparing the EQ-5D-5L utility index based on value sets of different countries: impact on the interpretation of clinical study results |
title_short |
Comparing the EQ-5D-5L utility index based on value sets of different countries: impact on the interpretation of clinical study results |
title_full |
Comparing the EQ-5D-5L utility index based on value sets of different countries: impact on the interpretation of clinical study results |
title_fullStr |
Comparing the EQ-5D-5L utility index based on value sets of different countries: impact on the interpretation of clinical study results |
title_full_unstemmed |
Comparing the EQ-5D-5L utility index based on value sets of different countries: impact on the interpretation of clinical study results |
title_sort |
comparing the eq-5d-5l utility index based on value sets of different countries: impact on the interpretation of clinical study results |
publisher |
BMC |
series |
BMC Research Notes |
issn |
1756-0500 |
publishDate |
2019-01-01 |
description |
Abstract Objective To compare the country-specific value sets of the EQ-5D-5L utility index and to evaluate the impact on the interpretation of clinical study results. Six country value sets from Canada, England, Japan, Korea, Netherlands and Uruguay were obtained from literature. In addition, ten crosswalk value sets were downloaded from the EuroQol.org website. Results For each of the 3125 possible health states the difference between the country with the highest index and the country with the lowest index was calculated. The median difference was 0.417 across the health states. When analyzing multinational clinical studies, country-specific value sets should be used to evaluate treatment effects. Additional country-specific analyses are needed. |
topic |
EQ-5D-5L utility index Clinical studies Country differences Quality of life valuation |
url |
http://link.springer.com/article/10.1186/s13104-019-4067-9 |
work_keys_str_mv |
AT christophgerlinger comparingtheeq5d5lutilityindexbasedonvaluesetsofdifferentcountriesimpactontheinterpretationofclinicalstudyresults AT lukebamber comparingtheeq5d5lutilityindexbasedonvaluesetsofdifferentcountriesimpactontheinterpretationofclinicalstudyresults AT friedhelmleverkus comparingtheeq5d5lutilityindexbasedonvaluesetsofdifferentcountriesimpactontheinterpretationofclinicalstudyresults AT carstenschwenke comparingtheeq5d5lutilityindexbasedonvaluesetsofdifferentcountriesimpactontheinterpretationofclinicalstudyresults AT claudiahaberland comparingtheeq5d5lutilityindexbasedonvaluesetsofdifferentcountriesimpactontheinterpretationofclinicalstudyresults AT gildaschmidt comparingtheeq5d5lutilityindexbasedonvaluesetsofdifferentcountriesimpactontheinterpretationofclinicalstudyresults AT janendrikat comparingtheeq5d5lutilityindexbasedonvaluesetsofdifferentcountriesimpactontheinterpretationofclinicalstudyresults |
_version_ |
1724937379299459072 |